Call For Abstracts
Australian and New Zealand Plastic Surgeons have been at the forefront of clinical research within our craft group for many decades. Our opinions are sought and well-received and yet there is a vast untapped well of knowledge and experience within our membership. The Australasian Society of Aesthetic Plastic Surgeons (ASAPS) invites you to consider submitting an abstract for oral presentation at the Breast Masters Symposium (BMS).
Abstracts will be considered from Plastic Surgeons, Plastic Surgery Trainees and Plastic Surgery Research Fellows. They will be considered in two broad categories, clinical and research.
Submitted papers will be assessed by the BMS committee and scored according to level of evidence, content/relevance, methodology and results. Abstracts without results will not be considered and it will not be considered adequate to state “the results will be discussed”.
Submissions must conform to the submission guidelines outlined by the BMS Committee below. Presentations are expected in a generic format without unnecessary reference to brand names/products and should be the original work of the authors. While there may be only one presenting author, multiple authors may be listed on the submission. Authors must disclose if their work has been presented or submitted elsewhere for presentation or publication. Where applicable, all studies must have been approved by an Institutional Review Board on the ethics of experimental and human/animal investigations.
Submission of an abstract acknowledges your acceptance for the abstract to be published in any printed material relating to the meeting and also your acceptance of the ASAPS Guest Speaker Policy. The final date for submission will be July 29, 2018.
|27 June 2018||Abstracts open|
|29 July 2018||Abstracts close (Midnight AEST. Strictly no extensions)|
|22 August 2018||Successful authors notified|
|31 August 2018||Authors must complete meeting registration|
Presentations will be 7 to 10 minutes in duration or as appropriate for the program if not in a free paper session.
Audiovisual equipment will be available in either PowerPoint or Keynote formats. Multimedia clips should be embedded in your slides. All presentations submitted as free papers should be provided to the AV team on a USB stick four hours prior to the start of the session in which you are presenting. In this category of presentation, you will not be able to present from your own laptop.
All abstracts are to be submitted via the online submission process on the conference website. Submission by email, fax or post will not be accepted. Do not include symbols, tables, pictures or diagrams within the “content” of your abstract.
Abstract review process:
Abstracts will be reviewed by members of the Breast Masters Symposium Committee. Notification regarding the status of abstract submission/acceptance will be by August 22, 2018. Presenters will need to make their own travel and accommodation arrangements including meeting registration. Successful presenters must have completed meeting registration by Friday August 31, 2018.
Disclosures and conflicts of interest:
The first slide of all presentations must include: presenter name, title, level of evidence and disclosures/conflicts of interest. The language of all presentations is expected to be generic and non-commercial where applicable avoiding the unnecessary use of brand names/products.
Consent for the use of images:
Qualified members of the media may be in attendance at the scientific sessions in the interest of public education. While the society does not knowingly permit cameras or other recording devices into the scientific program ASAPS realises that security measures, signs and announcements may not be totally effective and that no realistic limits may be placed upon the use of any information obtained by the media or attendees. Presenters are solely responsible for having obtained appropriate patient releases for all photographs that will be shown during their presentations and for any other information presented that might allow identification of patients. Written consent for the use of clinical images used in any presentation is expected and should be broad enough to cover all aspects of the presentation including the possibility of media or public exposure.
|Length||Maximum 300 words|
|Title||Limited to 20 words in sentence case (i.e. capital letters are used for the first letter of the first word and proper nouns; all other words are lower case).|
|Author and Co-Authors’
|Include all authors. The first author will be presumed to be the presenting author unless otherwise specified at abstract submission.|
|Required abstract structure||
|Abbreviations||Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appears the first time. Use generic names for drugs. Express numbers as numerals.|
|Tables||1 table of up to 10 rows x 5 columns can be included per abstract.|
|Graphs||1 graph can be included per abstract.
Images/graphs can be .jpg and should be 300dpi (where possible) when scaled to 100%. Please note that these may be resized to fit in the final printed material.